Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. That said, here are three stocks where the skepticism is well-placed and some better opportunities to consider.
Twilio (TWLO)
Consensus Price Target: $263.04 (-13.1% implied return)
Known for the clever "Twilio Magic" demo that had developers creating functioning communications apps in minutes, Twilio (NYSE:TWLO) provides a platform that enables businesses to communicate with their customers through voice, messaging, email, and other digital channels.
Why Is TWLO Not Exciting?
- Annual revenue growth of 14.7% over the last two years was below our standards for the software sector
- Sky-high servicing costs result in an inferior gross margin of 48.6% that must be offset through increased usage
- Operating margin improvement of 3.7 percentage points over the last year demonstrates its ability to scale efficiently
Twilio’s stock price of $302.68 implies a valuation ratio of 7.4x forward price-to-sales. If you’re considering TWLO for your portfolio, see our FREE research report to learn more.
AGCO (AGCO)
Consensus Price Target: $124.73 (7.3% implied return)
With a history that features both organic growth and acquisitions, AGCO (NYSE:AGCO) designs, manufactures, and sells agricultural machinery and related technology.
Why Are We Out on AGCO?
- Sales stagnated over the last five years and signal the need for new growth strategies
- Earnings per share have contracted by 5.5% annually over the last five years, a headwind for returns as stock prices often echo long-term EPS performance
- Diminishing returns on capital suggest its earlier profit pools are drying up
At $116.25 per share, AGCO trades at 17.7x forward P/E. Check out our free in-depth research report to learn more about why AGCO doesn’t pass our bar.
Integer Holdings (ITGR)
Consensus Price Target: $121.80 (-3.7% implied return)
With its name reflecting the mathematical term for "whole" or "complete," Integer Holdings (NYSE:ITGR) is a medical device outsource manufacturer that produces components and systems for cardiac, vascular, neurological, and other medical applications.
Why Are We Wary of ITGR?
- Muted 6.1% annual revenue growth over the last two years shows its demand lagged behind its healthcare peers
- Modest revenue base of $1.84 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Estimated sales growth of 1.5% for the next 12 months implies demand will slow from its two-year trend
Integer Holdings is trading at $126.48 per share, or 18.9x forward P/E. To fully understand why you should be careful with ITGR, check out our full research report (it’s free).
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.